Pharmacokinetic comparision of berberine in plasma after oral administration of pure berberine in no

来源 :第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu | 被引量 : 0次 | 上传用户:huang267321
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  In the present study, post inflammation irritable bowel syndrome(PI-IBS) rats were firsty established by intracolonic instillation of acetic acid with restraint stress.Then the pharmacokinetics of berberine in rat plasma were compared after oral administration of pure berberine in normal and PI-IBS rats by UPLCMS/MS.All the rats were received a gavages at a dosage of berberine 25mg/kg according to body weight.The pharmacokinetics parameters were analyzed by WinNonlin software.The results indicated that the pharmacokinetics of berberine in rat plasma was different between in normal and PI-IBSrats.Especially, it is worth mentioning that the total amount of berberine absorbed is more larger and the rate of elimination and metabolism is more slower in PI-IBS rats than those of rats in normal control.
其他文献
Aim:To assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single, escalating subcutaneousinjections of an albumin-Exendin-4 conjugate in healthy rhesus monkeys.Methods:This stud
会议
Background:Concentration dependent Blood to plasma ratio (B/P) of zonisamide(ZNS) was observed in clinical trial, which requires measuring both plasma concentration and whole blood concentration for c
会议
The aim of the present study was to development a pharmacokinetic/pharmacodynamic (PK/PD) model for the characterization ofperindopril effect in spontaneously hypertensive rats (SHRs) while taking int
会议
Background: The aim of this study was to establish a causal disease progression model quantifying the sequential change of biomarkers and their relative values as predictors of different Alzheimers Di
Background: Risperidone, an anatypical antipsychotic agent, characterized as an antagonist of dopaminergic and serotonergic receptors, is now widely used in the treatment of patients with positive sym
会议
Exenatide (glucagon-like-peptide-1 analogue) was authorized for marketing in the European Union in November 2006 and was approved by FDA in April 2005.To improve compliance, exenatide double-walled mi
会议
Valproic acid (VPA) is an important drug in treatment of childhood epilepsy, however, VPA concentration should be monitored during epilepsy treatment.The aim of this study was to realize personalized
会议
Objevtive:To study the population pharmacokinetics of clozapine conventional tablets and disintegrating tablets in Chinese healthy volunteers.Methods:Fourty-two Chinese healthy volunteers were given 2
Objective:In vitro information on dextromethorphan (DXM) and the Advanced Dissolution Absorption Metabolism (ADAM) model, incorporated into PBPK simulator Simcyp(@) (v.12) were used to investigate dif
会议
Diabetes mellitus is one of the most common chronic disease in the world, CPRC 1 is a novel dipeptidylpeptidase-Ⅳ(DPP-4) inhibitor which was proposed to control hyperglycemia in patients with type 2 d
会议